Clinical Trial Update: The Effect of Probiotics on Depression Syndrome and Risk Factors of Cardiovascular Disease in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of probiotics on depression symptoms and cardiovascular risk factors in hemodialysis patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Major Depressive Disorder

Snippet

Sponsor: China Medical University Hospital | Conditions: Depression Mild, Cardiovascular Diseases | Phase 4 | Status: COMPLETED